Bing Sun

1.7k total citations
76 papers, 1.1k citations indexed

About

Bing Sun is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Bing Sun has authored 76 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 32 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Bing Sun's work include Lung Cancer Treatments and Mutations (14 papers), Brain Metastases and Treatment (11 papers) and Lung Cancer Diagnosis and Treatment (8 papers). Bing Sun is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Brain Metastases and Treatment (11 papers) and Lung Cancer Diagnosis and Treatment (8 papers). Bing Sun collaborates with scholars based in China, United States and Canada. Bing Sun's co-authors include Shikai Wu, Xiangying Meng, Chao Liu, Zhou Huang, Santai Song, Eric D. Brooks, Stephen M. Hahn, Daniel R. Gomez, Michael S. O’Reilly and John V. Heymach and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Bing Sun

70 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bing Sun China 19 482 380 254 193 131 76 1.1k
M. Lloret Spain 20 205 0.4× 311 0.8× 231 0.9× 179 0.9× 56 0.4× 50 890
Eileen P. Connolly United States 20 182 0.4× 298 0.8× 364 1.4× 354 1.8× 47 0.4× 68 1.2k
Adeel Kaiser United States 16 232 0.5× 167 0.4× 218 0.9× 68 0.4× 24 0.2× 66 939
Junru Wang United States 19 297 0.6× 191 0.5× 298 1.2× 77 0.4× 96 0.7× 35 1.2k
Huaien Zheng Canada 15 196 0.4× 286 0.8× 251 1.0× 74 0.4× 121 0.9× 25 1.1k
Aya Harada Japan 14 174 0.4× 123 0.3× 223 0.9× 40 0.2× 93 0.7× 29 877
Fang‐Yun Xie China 18 265 0.5× 415 1.1× 328 1.3× 181 0.9× 49 0.4× 69 1.2k
Xiaojiang Sun China 20 330 0.7× 254 0.7× 253 1.0× 152 0.8× 30 0.2× 61 1.1k
Seo Hee Choi South Korea 16 229 0.5× 328 0.9× 149 0.6× 164 0.8× 13 0.1× 88 1.0k

Countries citing papers authored by Bing Sun

Since Specialization
Citations

This map shows the geographic impact of Bing Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Sun more than expected).

Fields of papers citing papers by Bing Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Sun. The network helps show where Bing Sun may publish in the future.

Co-authorship network of co-authors of Bing Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Sun. A scholar is included among the top collaborators of Bing Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Sun. Bing Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Yanli, Rong Zhang, Wei Ding, et al.. (2025). The efficacy and safety analysis of oral isavuconazole therapy of invasive pulmonary aspergillosis. Journal of Chemotherapy. 38(1). 25–31.
2.
Sun, Bing, Liyang Zhao, Xing Su, et al.. (2024). Exploring the most discriminative brain structural abnormalities in ASD with multi-stage progressive feature refinement approach. Frontiers in Psychiatry. 15. 1463654–1463654. 2 indexed citations
3.
Lin, Dongxin, et al.. (2024). A survey of the research on quantum circuit synthesis and optimization of symmetric-key cryptography. Zhongguo kexue. Wulixue Lixue Tianwenxue. 55(4). 240303–240303. 1 indexed citations
4.
Zhang, Liang, Zhaoming Ding, Jihua Han, et al.. (2024). Recurrence and postoperative quality of life after surgical resection of unilateral cT1–T3N1bM0 papillary thyroid carcinoma. Gland Surgery. 13(10). 1740–1751. 2 indexed citations
5.
Liu, Chao, Min Zhang, Xinlong Yan, et al.. (2023). Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression. Science Advances. 9(4). eadd8977–eadd8977. 65 indexed citations
6.
Liu, Chao, Xiaohui Li, Qingyu Huang, et al.. (2023). Single-cell RNA-sequencing reveals radiochemotherapy-induced innate immune activation and MHC-II upregulation in cervical cancer. Signal Transduction and Targeted Therapy. 8(1). 44–44. 66 indexed citations
7.
Chen, Yi, Xin Wang, Bing Sun, et al.. (2022). [Expert Consensus on the Treatment of Antiangiogenic Agents for Radiation Brain Necrosis].. SHILAP Revista de lepidopterología. 25(5). 291–294. 2 indexed citations
8.
Liu, Chao, Kai Wang, Luyuan Li, et al.. (2021). Severity of COVID-19 in Cancer patients versus patients without Cancer: A Propensity Score Matching Analysis. Journal of Cancer. 12(12). 3558–3565. 3 indexed citations
9.
Jiang, Shaoyan, et al.. (2018). Renin-angiotensin system inhibitor attenuates oxidative stress induced human coronary artery endothelial cell dysfunction via the PI3K/AKT/mTOR pathway. Archives of Medical Science. 15(1). 152–164. 25 indexed citations
10.
Liu, Chao, Bing Sun, Bin Xu, et al.. (2018). A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease. Cancer Management and Research. Volume 10. 1749–1761. 24 indexed citations
11.
Liu, Chao, Wei Wang, Xiangying Meng, et al.. (2018). Albumin/globulin ratio is negatively correlated with PD-1 and CD25 mRNA levels in breast cancer patients. OncoTargets and Therapy. Volume 11. 2131–2139. 13 indexed citations
12.
Wang, Yue, Huiru Sun, Xiangying Meng, Bing Sun, & Santai Song. (2018). Analysis of radiotherapy strategy for 110 breast cancer patients after R0 resection of local recurrence after radical mastectomy. Zhonghua fangshe yixue yu fanghu zazhi. 38(9). 670–674. 1 indexed citations
13.
Sun, Bing, Eric D. Brooks, Ritsuko Komaki, et al.. (2017). Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non–Small Cell Lung Cancer: A Phase II Clinical Trial. Journal of Thoracic Oncology. 12(6). 983–992. 52 indexed citations
14.
Liu, Chao, Lijuan Ding, Bing Sun, & Shikai Wu. (2016). Bilateral breast adenocarcinomas with EML4—ALK fusion in a patient with multiple metastases successfully treated with crizotinib: is lung the primary site?. OncoTargets and Therapy. 9. 3589–3589. 2 indexed citations
15.
Sun, Bing, Zhou Huang, Shikai Wu, et al.. (2015). Incidence and relapse risk of intracranial metastases within the perihippocampal region in 314 patients with breast cancer. Radiotherapy and Oncology. 118(1). 181–186. 29 indexed citations
16.
17.
Sun, Bing, Santai Song, Tao Wang, et al.. (2013). [Analysis of the factors affecting pathologic complete response to neoadjuvant chemotherapy in breast cancer patients].. PubMed. 35(1). 38–42. 3 indexed citations
18.
Wu, Song, Zefei Jiang, Bing Sun, et al.. (2013). Progestin as an alternative treatment option for multi-treated recurrent triple-negative breast cancer. Swiss Medical Weekly. 143(2122). w13765–w13765. 4 indexed citations
19.
Sun, Bing, Feng Zhang, Shikai Wu, et al.. (2011). Gene Expression Profiling for Breast Cancer Prognosis in Chinese Populations. The Breast Journal. 17(2). 172–179. 12 indexed citations
20.
Sun, Bing, et al.. (2001). History of Chinese Stereotactic and Functional Neurosurgery. Stereotactic and Functional Neurosurgery. 77(1-4). 17–19. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026